RFA-HL-23-003: Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.
National Institutes of Health offered grants of up to $250,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on March 28, 2024.
From the official notice on Grants.gov, last changed January 6, 2022. Checked November 7, 2026.
- Award ceiling$250,000
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeR00
- Clinical trialsOptional
- Funded byNHLBI
- Median yearly award$426,023
- Typical project length3 years
- R00, Research Transition Award. The independent phase of the K99/R00 Pathway to Independence award. Other open R00 notices.
Projects funded under RFA-HL-23-003 were run by National Heart Lung and Blood Institute (NHLBI, 9 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-HL-23-003 in the NIH Guide.
Key dates
| Posted | January 5, 2022 |
|---|---|
| Deadline | March 28, 2024 |
| Archived by Grants.gov | May 3, 2024 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $426,023; it allows up to $250,000 per award.
- Most of the program's money (59% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The purpose of this limited competition R00 program is to provide physician scientists in blood science with a seamless pathway from a mentored K99/R00 award to investigator independence. Eligible applicants will have matriculated through the Career Pathway to Independence in Blood Science Awards for Physician Scientists ( K99/R00) program for up to three, but no more than five years. The strongest R00 applicants will propose an updated, well-conceived plan for 23 years of independent research support intended to prepare the applicant to subsequently compete for an R01 or equivalent award. These research projects are limited to those that fall within the Division of Blood Diseases and Resources mission. The NIH encourages institutions to recruit and retain individuals from groups currently underrepresented in the biomedical sciences, and to enhance the diversity of the clinician-investigator workforce (NOT-OD-15-053).
Funded under RFA-HL-23-003 so far
NIH funded 9 projects under RFA-HL-23-003 in fiscal 2024 to 2026, at 6 institutions. The median yearly award was $426,023.
Who has won Lung Diseases Research grants before
From fiscal 2021 to 2025, Lung Diseases Research (93.838) awarded $8.7 million across 5 grant awards, an average of $1.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The General Hospital Corporation | Massachusetts | 1 | $5.4 million |
| New England Research Institutes Inc | Massachusetts | 1 | $2.7 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | 1 | $355,699 |
| University of Washington | Washington | 1 | $350,272 |
| The Trustees of Columbia University in the City of New York | New York | 1 | $319,659 |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-HL-23-003 still open?
No. It closed on March 28, 2024.
Who can apply for Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)?
Closed March 28, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $250,000 each.
Who has been funded under RFA-HL-23-003?
NIH RePORTER lists 9 projects funded under RFA-HL-23-003 in fiscal 2024 to 2026, at 6 institutions. The most were at Children's Hosp of Philadelphia, Johns Hopkins University, Emory University.
Who has won Lung Diseases Research grants before?
The largest recipients over five fiscal years were The General Hospital Corporation, New England Research Institutes Inc, The Trustees of the University of Pennsylvania. The program made 5 awards worth $8.7 million in that time.
Similar open grants
- NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
- NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Mentored Career Transition Award (KT1/R00)
- NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
- NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)